Although not many study references were found in mice, Jacobs et al. [42] demonstrated that transgenic mouse models carrying AD mutations (AbetaPP / PS1, APPswe / PS1dE9) have evidenced the role for the cerebellum in the pathophysiology of sporadic AD and its clinical manifestations. The gene discussed is PSEN1; the disease is Alzheimer disease.